Reporting person on SEC Form 4

Nicole Murphy

Nicole Murphy is Head of Pharm Ops and Tech at Biogen. OQRO lists 11 transactions filed with the SEC under this name, the latest on Feb 18, 2026, each linked to the official Form 4.

Head of Pharm Ops and Tech

Disclosures on record

11

Companies involved

1

Their past purchases, 90 days after disclosure

1 buy, median −8.8% vs S&P 500, beat it 0 of 1 time.

Average −8.8% vs S&P 500. Each buy is one disclosure of open-market purchases in one company on one filing date, filed Feb 18, 2026 to Feb 18, 2026, measured from the first close after the filing. Past results, not a forecast.

Disclosure history

BiogenBIIB
11 disclosures · Feb 2026 · 1 bought
- Feb 12, 2026Bought~$585disclosed Feb 18
  Details Official record
- Feb 13, 202611Kdisclosed Feb 18
  Details Official record